Continuing medical education

CME Forum 2020: 5th Annual Advancements in Cancer Management

CME Forum is an educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Recordings of presentations, case studies and Q & A sessions are available on demand or as live webinars to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each on demand event.

Rapidly Scaling Oncology Telehealth Services

COVID-19 changed the landscape for many healthcare providers. In addition to creating a need for appointments with minimal contact, the Centers for Medicare and Medicaid relaxed and modified policy surrounding telehealth appointments to facilitate quick transition to virtual appointments. This education will share best practices and compliance considerations for deploying a pandemic response telehealth program, and recommendations for transitioning this program to a post-COVID world.

Upon completion of this activity, participants will be able to:

• Describe key practices and necessary system infrastructure for successful implementation of a telehealth program
• Discuss the importance of a targeted focus for a telehealth program in response to COVID-19
• Discuss the technological and legal considerations when launching a telehealth program
• Develop targeted telehealth programs and identify specific appointment types that can be appropriately addressed via telehealth appointments

Faculty:

• Jennifer Greenman, MBA (Cancer Treatment Centers of America)
• Gillian Leene, Esq. (Cancer Treatment Centers of America)
• Chevon Rariy, MD (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Jennifer Smith, MBA (Cancer Treatment Centers of America)

Lymphedema Management and Surgical Therapy

Lymphedema is a common side effect in patients with cancer. While surgical interventions may sometimes be necessary, there are many less invasive options as well which may effectively manage the condition for some patients. This program aims to discuss the latest data on methods of managing lymphedema, and how to determine which method is best for each patient.

Upon completion of this activity, participants will be able to:

• Describe the various techniques for treating lymphedema in patients with cancer
• Apply the appropriate method of lymphedema management to a specific patient

Faculty:

• Daniel Liu, MD (Cancer Treatment Centers of America)

Molecular Tumor Board Series 2020: Part I and Part II

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic/genomic testing, pathology and radiological imaging. Cases discussed include: gallbladder carcinoma, triple negative breast cancer, endometrial cancer and adenocarcinoma of unknown primary.

Upon completion of this activity, participants will be able to:

• Describe the necessary components of an effective molecular tumor board
• Explain how to integrate genomic profiling into oncology treatment plans

Faculty:

• Jason Beland, MD (Cancer Treatment Centers of America)
• Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Kimberly McGregor, MD (Foundation Medicine)
• Ankur Parikh, DO (Cancer Treatment Centers of America)
• Patricia Rich, MD (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Bradford Tan, MD (Cancer Treatment Centers of America)

Lung Nodules: Evaluation and Diagnostic Approaches

Clinicians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.

Upon completion of this activity, participants will be able to:

• Discuss the various diagnostic and staging procedures for lung nodules
• Select the appropriate approach and follow-up for high-risk patients with lung nodules

Faculty:

• Abdul Hamid Alraiyes, MD, FCCP (Cancer Treatment Centers of America)

Dysphagia Palliation in Esophageal Cancer

Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.

Upon completion of this activity, participants will be able to:

• Discuss the various modalities for management of dysphagia
• Select the appropriate modality for management of dysphagia in patients with esophageal cancer
• Explain the goals of palliative treatment in patients with esophageal cancer

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD (Banner MD Anderson)

Multidisciplinary Management of Rectal Cancer in Young Adults: Facts and Controversies

Due to recent recommendations regarding COVID-19 from the CDC and WHO, we are postponing our live CME events scheduled for March 2020. We will continue to monitor the situation and reschedule these events once it is safe to do so. At this time, events for April and May will proceed as scheduled but we will keep any registrants posted if those programs need to be changes as well. Please contact Sarah Lees, National CME Program Manager, with any questions at sarah.lees@ctca-hope.com

This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.

Upon completion of this activity, participants will be able to:

• Explain the different approaches for managing rectal cancer in young adults
• Identify the appropriate approach for the treatment of rectal cancer in young adults

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD, FACP (Banner MD Anderson)
• Nitin Mishra, MBBS, MPH (Mayo Clinic – Phoenix)